Of sheep and wolves: curtailing coverage for essential imaging tests based on flawed use and cost arguments
J Czernin, M Allen-Auerbach… - Journal of Nuclear …, 2019 - Soc Nuclear Med
In a recently published study (1) that compared 18F-fluciclovine with 68Ga-PSMA 11 for
detecting early biochemical prostate recurrence, Calais et al. provide a trial profile that …
detecting early biochemical prostate recurrence, Calais et al. provide a trial profile that …
Are health economics making us sick?
For those of us who have been involved with PET for the past 2 decades, it never ceases to
amaze that this technology struggled for so long to gain acceptance by funding bodies and …
amaze that this technology struggled for so long to gain acceptance by funding bodies and …
More unacceptable denials: now It's PSMA-targeted PET/CT imaging
J Czernin, T Adams, J Calais - Journal of Nuclear Medicine, 2022 - Soc Nuclear Med
Following in the footsteps of others (1), we have written about insurance denials. We argued
about it in the context of 18 F-FDG PET/CT imaging (2), 68 Ga-DOTATATE imaging (3), 177 …
about it in the context of 18 F-FDG PET/CT imaging (2), 68 Ga-DOTATATE imaging (3), 177 …
[PDF][PDF] Humana and 18F-FDG PET/CT: Another sequel to the injustice of being judged by the errors of others
J Czernin, A Iagaru - Journal of Nuclear Medicine, 2021 - Soc Nuclear Med
Humana, the feminine for humanus in Latin, is taken to mean ''human (of man,
people)'';''humane'';''cultured, refined''(1). Humana, a for-profit American health insurance …
people)'';''humane'';''cultured, refined''(1). Humana, a for-profit American health insurance …
SNMMI comment on ASCO 2013 “Choosing wisely” recommendation on use of PET/CT in recurrent cancer surveillance
EM Rohren, GL Dillehay, H Jadvar - Journal of Nuclear Medicine, 2014 - Soc Nuclear Med
(SNMMI) would like to comment on the recent publication of the American Society of Clinical
Oncology (ASCO) Top Five List in Oncology as part of the Choosing Wisely Campaign …
Oncology (ASCO) Top Five List in Oncology as part of the Choosing Wisely Campaign …
A consideration for changing our PET data saving practices: a cost/benefit analysis
1912 Objectives Every PET scanner produces raw acquisition data which is used to
generate an image, and this data is almost universally discarded beyond its initial use. Most …
generate an image, and this data is almost universally discarded beyond its initial use. Most …
Out with the Old, in with the New: Can We Bridge the Gap Between Clinical Trial Results Based on Bone Scans and the Era of Modern Prostate Cancer Imaging?
Prostate cancer is a significant contributor to overall cancerrelated morbidity and mortality
(1). Accurate disease staging is a critical component in making informed therapeutic …
(1). Accurate disease staging is a critical component in making informed therapeutic …
68Ga or 18F for prostate cancer imaging?
Prostate-specific membrane antigen (PSMA) is a type II transmembrane glycoprotein with
enzymatic carboxypeptidase activity. Expression is seen at low levels in the brain, kidneys …
enzymatic carboxypeptidase activity. Expression is seen at low levels in the brain, kidneys …
Disparities in PET imaging for prostate cancer at a tertiary academic medical center
MD Bucknor, DY Lichtensztajn, TK Lin… - Journal of Nuclear …, 2021 - Soc Nuclear Med
The purpose of this study was to evaluate differences between patients receiving 18F-
fluciclovine and 68Ga-prostate-specific membrane antigen (68Ga-PSMA-11) for …
fluciclovine and 68Ga-prostate-specific membrane antigen (68Ga-PSMA-11) for …
HCFA expands Medicare coverage of PET
D Kotz - The Journal of Nuclear Medicine, 1999 - search.proquest.com
In a welcome bit of news for nuclear physicians, the Health Care Financing Administration
(HCFA) announced on March 8 that it would cover additional uses of PET scans to diagnose …
(HCFA) announced on March 8 that it would cover additional uses of PET scans to diagnose …